Login / Signup

Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.

Christopher DittusJordan A MillerRobert WehbieJorge J Castillo
Published in: British journal of haematology (2022)
Keyphrases
  • multiple myeloma
  • diffuse large b cell lymphoma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • phase ii study
  • squamous cell carcinoma
  • clinical trial
  • radiation therapy
  • combination therapy
  • phase iii